Influence of Class I interferons on performance of vascular cells on stent material in vitro

Cardiovascular Radiation Medicine

Volumn 3, Issue 2, 2002, Pages 82-90

  Kipshidze, Nicholas ^a,d   Moussa, Issam ^a   Chekanov, Valeri ^c   Nikolaychik, Victor ^b   Khanna, Ashwani ^b   Colombo, Antonio ^a   Leon, Martin B ^a   Moses, Jeffrey ^a  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Milwaukee Heart Institute   (United States)

^d Lenox Hill Heart/Vascular Institute   (United States)

Author keywords

Interferon; Restenosis; Smooth muscle cell; Stents

Indexed keywords

CD31 ANTIGEN; FIBRIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; VASCULOTROPIN;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY STENT; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBROBLAST; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOREACTIVITY; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SMOOTH MUSCLE FIBER; SURFACE PROPERTY; UPREGULATION;

EID: 0036556874     PISSN: 15221865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-1865(02)00155-5     Document Type: Article

References (36)

1. Topol E.J., Serruys P.W. Frontiers in interventional cardiology. Circulation. 98:1998;1802-1820.
2. Kuntz R.E., Gison C.M., Nobuyoshi M., Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 21:1993;15-25.
3. Ahmed J.M., Mintz G.S., Castagna M., Weissman N.J., Pichard A.D., Satler L.F., Kent K.M. Intravascular ultrasound assessment of the mechanism of lumen enlargement during cutting balloon angioplasty treatment of in-stent restenosis. Am J Cardiol. 88(8):2001;1032-1034.
4. Herdeg C., Oberhoff M., Baumbach Aet al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol. 35(7):2000;1969-1976.
5. Serruys P.W., Degertekin M., Tanabe K., Abizaid A., Sousa J.E., Colombo A., Guagliumi G., Wijns W., Lindeboom W.K., Ligthart J., de Feyter P.J., Morice M.C. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirollmus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 106(7):2002;798-803.
6. Crook M.F., Newby A.C., Southgate K.M. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture. Atherosclerosis. 150(1):2000;33-41. May.
7. Shin W.S., Hong Y.H., Peng H.B., De Caterina R., Libby P., Liso J.K. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J Biol Chem. 271(19):1996;11317-11324. May 10.
8. Stein C.S., Fabry Z., Murphy S. Involvement of nitric oxide in IFN-gamma-mediated reduction of microvessel smooth muscle cell proliferation. Mol Immunol. 32(13):1995;965-973. Sep.
9. Lelkes P.I., Ramos E., Nikolaychik V.V., Wankowski D.M., Unsworth B.R., Goodwin T.J. GTSF-2, a new, versatile call culture medium for diverse normal and transformed mammalian cells. In Vitro Cell Div Biol Admin. 38:1997;334-351.
10. Dunlop P., Porter K., Varty K., London N. Effect of recombinant growth factors on human saphenous vein smooth muscle cells. In Vitro Cell Div Biol Admin. 34:1998;431-438.
11. Dzirlo-Todorovich J. Culture of endothelial cells as an in vitro model for experimental and clinical research. Med Arh. 50(3-4):1986;76-79.
12. Nikolachik V.V., Samet M.M., Lelker P.I. A new method for continual quantitation of viable cells on endothelialized polyurethanes. J Biomater Sci. 7:1996;881-891.
13. Yan D.H., Wen Y., Spohn B., Choubey D., Gutterman J.U., Hung M.C. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene. 18(3):1999;807-811.
14. Gutterman J.U. Clinical investigators: the driving force behind drug discovery. Nat Biotechnol. 15(7):1997;598-599.
15. Mujoo K., Maneval D.C., Anderson S.C., Gutterman J.U. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. Oncogene. 12(8):1996;1617-1623.
16. Autieri M.V., Agrawal N. IRT-1, a novel interferon-gamma-responsive transcript encoding a growth-suppressing basic lecine zipper protein. J Biol Chem. 273(24):1998;14731-14737.
17. Johnson B., Pitt B., Davies P. Pulmonary arterial smooth muscle cells modulate cytokine- and LPS-induced cytotoxicity in endothelial cells. AJP-Lung Cellular Molecular Physiol. 278(3):2000;L460-L468.
18. Stephan D., San H., Yang Z., Gordon D., Goetz S., Nabel G.J., Nabel E.G. Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol Med. 3(9):1997;593-599.
19. Wang X., Li X., Yue T. Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. Biochem Biophys Acta. 1500(1):2000;41-48.
20. Tashiro H., Shimokawa H., Sadamatsu A., Aoki T., Yamamoto K. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty. Coron Artery Dis. 12(92):2001;107-113.
21. Selzman C.H., Shames B.D., Whitehill T.A., Harken A.H., McIntyre R.C. Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation. Surgery. 124(2):1998;318-326.
22. Hansson G.K. Immunological control mechanisms in plaque formation. Basic Res Cardiol. 89(Suppl. 1):1994;41-46.
23. Castronuovo J.J., Guss S.B., Mysh D., Sawbney A., Wolff M., Gown A.M. Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by gamma-interferon. Cardiovasc Surg. 3(5):1995;463-468.
24. Kern A., Liu K., Mansbridge J. Modification of fibroblast gamma-interferon responses by extracellular matrix. I Invest Dermatol. 117(1):2001;112-118.
25. Zohlnhofer D., Richter T., Neumann F., Nuhrenberg T., Wessely R., Brandl R., Murr A., Klein C.A., Baeuerle P.A. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell. 7(5):2001;1059-1069.
26. Ribault S., Neuville P., Mechine-Neuville A., Auge F., Parlakian A., Gabbiani G., Paulin D., Calenda V. Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ Res. 88(5):2001;468-475.
27. Autieri M., Carbone C., Mu A. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth cells and arterial injury. Atheroscler Thromb Vasc Biol. 20(7):2000;1737-1744.
28. Liu L., Lalani A., Dai E., Seet B., Macauley C., Singh R., Fan L., McFadden G., Lucas A. The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest. 105:2000;1613-1621.
29. Delmolino L.M., Castellot J.J. Heparin suppresses sqk, an early response gene in proliferating vascular smooth muscle cells. J Cell Physiol. 173(3):1997;371-379.
30. Mintzer R.J., Croze E., Rubanyi G.M., Johns A. Differential effects of IFN-beta 1b on the proliferation of human vascular smooth muscle and endothelial cells. J Interferon Cytokine Res. 18(11):1998;939-945.
31. Gaydos C.A. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis. 181(Suppl. 3):2000;S473-S478. June.
32. Hofma S.H., van Beusekom H.M., Serruys P.W., Vander Giessen W.Y. Recent developments in coated stents. Curr Interv Cardiol Rep. 3(1):2001;28-36.
33. Mintzer R.J., Croze E., Rubanyi G.M. Differential effects of IFN-beta 1B on the proliferation of human vascular smooth muscle and endothelial cells. J Interferon Cytokine Res. 18(11):1998;935-945.
34. Wang X., Yue T.L., Ohlstein E.H. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem. 271(39):1996;24286-24293.
35. Bennett M.R., Littlewood T.D., Hancock D.C., Evan G.F., Newby A.C. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth muscle cell proliferation: a signal for growth arrest? Biochem J. 302(Pt3):1994;701-708.
36. Manka D., Collins R.G., Ley K., Beadet A.L., Sarembock I.J. Absence of P-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein E-deficient mice. Circulation. 103(7):2001;1000-1005.